Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence

Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial

(2016) Mascha Nuijten et al.   LANCET

Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

(2015) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010

(2014) Louisa Degenhardt et al.   DRUG AND ALCOHOL DEPENDENCE

Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats

(2013) Helen L Rowley et al.   JOURNAL OF PSYCHOPHARMACOLOGY

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

(2013) A.-W. Chan et al.   BMJ-British Medical Journal

Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings

(2012) William J. Panenka et al.   DRUG AND ALCOHOL DEPENDENCE

Agonist replacement therapy for cocaine dependence: a translational review

(2012) Craig R Rush et al.   Future Medicinal Chemistry

Extent of illicit drug use and dependence, and their contribution to the global burden of disease

(2012) Louisa Degenhardt et al.   LANCET

Lisdexamfetamine and immediate release d-amfetamine – Differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity

(2012) H.L. Rowley et al.   NEUROPHARMACOLOGY

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

(2012) Sandra D. Comer et al.   PAIN

The drug effects questionnaire: psychometric support across three drug types

(2012) Meghan E. Morean et al.   PSYCHOPHARMACOLOGY

Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate

(2011) James C. Ermer et al.   CLINICAL DRUG INVESTIGATION

Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies

(2010) David V. Herin et al.   Annals of the New York Academy of Sciences

A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction

(2010) G P Galloway et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

(2010) Pennick   Neuropsychiatric Disease and Treatment

Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence

(2009) Marie Longo et al.   ADDICTION

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

(2009) DR Jasinski et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials

(2008) M. J. Eisenberg et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers

(2008) DR Jasinski et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pharmacotherapy of Methamphetamine Addiction: An Update

(2008) Ahmed Elkashef et al.   Substance Abuse